Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 21, 2026The Anatolian Journal of CardiologyOpen Access

Comment on “Dysregulation of Serum miR-212- 3p Serves as a Biomarker to Predict Disease Onset and Short Term Prognosis in Acute Coronary Syndrome Patients”

View Full Paper
Ask AI
Bookmark
Share

Authors

NŞNurcemal ŞentürkKaradeniz Technical UniversityACAdnan Duha CömertUni Research (Norway)

Discussion

Loading...

Member takes

Implication

This comment discusses serum miR-212-3p's potential as a biomarker in acute coronary syndrome, suggesting implications for diagnosis and prognosis.

Key Points

  • The commentary addresses the utility of serum miR-212-3p as a biomarker for acute coronary syndrome.
  • Review of findings from a related study on miR-212-3p
  • Evaluation of statistical metrics like area under the curve and hazard ratios
  • Critique of methodological issues impacting clinical relevance
  • Serum miR-212-3p showed a strong association with major adverse cardiovascular events.
  • An area under the curve of 0.952 indicates high diagnostic accuracy.
  • A hazard ratio of 5.077 suggests a significant risk factor for adverse outcomes.

Cite This Study

Şentürk et al. (2026) studied this question.

synapsesocial.com/papers/69be34d16e48c4981c672f78https://doi.org/10.14744/anatoljcardiol.2025.6050
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dysregulation of Serum miR-212-3p Serves as a Biomarker to Predict Disease Onset and Short-Term Prognosis in Acute Coronary Syndrome Patients2025 · 1 citations
  2. 2Upregulation of Serum miRNA-3615 Serves as a Biomarker to Predict Disease Onset and Prognosis in Acute Coronary Syndrome Patients2026
  3. 3Downregulation of serum miR-30c-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients2025 · 6 citations
  4. 4Serum miR-497-5p serves as a diagnostic biomarker for acute coronary syndrome and predicts the occurrence of major adverse cardiovascular events after percutaneous coronary intervention2022 · 16 citations
  5. 5The Potential of Downregulated Serum miR-1282 to Predict Disease Onset and Short-Term Prognosis in Acute Coronary Syndrome Patients2025